Live Breaking News & Updates on Medical Congresses

Stay updated with breaking news from Medical congresses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Altimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Yasmeen Rahimi , Vipin Garg , Scot Roberts , Piper Sandler , Scott Harris , Technology Dividend Aristocrats To , Altimmune Inc , Call Transcript May , First Quarter , Results Conference , Rich Eisenstadt , Chief Financial Officer , Chief Executive Officer , Chief Scientific Officer , Chief Medical , Investor Relations , Safe Harbor , Private Securities Litigation Reform Act , Chief Medical Officer , Medical Congresses , Technology Dividend Aristocrats , Most Pollution , Roger Song , Unidentified Analyst , Chang Yuan ,

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc. ....

United States , Sean Kim , Vikram Purohit , Tyler Van Buren , Seamus Fernandez , Frank Watanabe , John Smither , Chris Shibutani , Serge Belanger , Patrick Burnett , Arcutis Biotherapeutic , Todd Edwards , Derek Cole , Arcutis Biotherapeutics Inc , Goldman Sachs , Trademark Office , Morgan Stanley , Exchange Commission , Call Transcript February , Full Year Financial Results Conference , Arcutis Investor , Chief Medical Officer , Chief Commercial Officer , Chief Financial , Janus Kinase , Medical Congresses ,

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript February 27, 2024 Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […] ....

Frank Watanabe , Patrick Burnett , Medical Congresses , Lasting Jeans Brands , Ecommerce Companies ,

CPAF - Cancer Patient Advocate Foundation

CPAF - Cancer Patient Advocate Foundation
drleonardcoldwell.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drleonardcoldwell.com Daily Mail and Mail on Sunday newspapers.

United States , Leonard Coldwell , Foundation For Drug , Schmargendorf Health Institute , Cancer Patient Advocate Foundation , Health For Children , Cancer Society , Board Certified Holistic Health Practitioner , Voice For Cancer , Cancer Patient , Thomas Hohn , Root Cause , Crime Free Schools , American Anti Cancer Society , Medical Congresses , General Practitioner , Natural Medicine , Board Certified Alternative Medical Practitioner ,

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2022 Earnings Call Transcript

John Lacey: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. ....

United States , Phil Serlin , Holly Mae , Mark Breidenbach , Philip Serlin , Ella Sorani , John Lacey , Joe Pantginis , John Vandermosten , Abi Vainstein , Abi Vainstein Haras , Washington University , American Society For Hematology Meeting , Advisory Committee , Development Collaboration Agreement , Biolinerx Ltd , Columbia University , Call Transcript November , Chief Executive Officer , Investor Relations , Mali Zeevi , Chief Financial Officer , Chief Medical Officer , Chief Development Officer , Holly May , Biolinerx United ,